Consistent with our findings, a transgenic adenocarcinoma of mouse prostrate (TRAMP) model has demonstrated that oral administration of piceatannol, derived from PFBE, reduced TNF-α levels in the liver of mice [34]. Here, TNF is linked to adenocarcinoma.